Aug 1, 2012 | Recent Deals | Silicon Valley
O’Melveny & Myers LLP represented CytomX Therapeutics Inc. in the expansion of its Series B round, bringing the total raised to US$41 million.
O’Melveny’s Silicon Valley-based team was led by partners Sam Zucker and Jennifer DePalma and associate Ruchun Ji.
Related Posts:
- O’Melveny Represents Dicerna Pharmaceuticals in US$60 Million Private Financing Transaction
- O’Melveny Represents Alliance Health Networks in Acquisition of Medify
- O’Melveny Represents Celsion Corporation in a US$15 Million Private Placement
- O’Melveny Represents Celsion in Registered Direct Offering
- O’Melveny Represents Progenics Pharmaceuticals in Proposed Public Offering